BGLAF (BioGaia AB) Cyclically Adjusted PB Ratio: (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGLAF BioGaia AB BGLAF
100 GF Score
Price $12.20
GF Value $12.57
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is BioGaia AB Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioGaia AB  (OTCPK:BGLAF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioGaia AB Cyclically Adjusted PB Ratio Related Terms


BioGaia AB Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Cyclically Adjusted PB Ratio Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.85 9.15 9.19 9.08 8.09

BioGaia AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.28 8.27 8.09 8.95 0.00

BGLAF vs ZTS, UTHR: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted PB Ratio falls into.


BGLAF
100GF Score
BioGaia AB BGLAF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioGaia AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, BioGaia AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.144/134.1100*134.1100
=1.144

Current CPI (Jun. 2026) = 134.1100.

BioGaia AB Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.500 101.138 0.663
201612 0.520 102.022 0.684
201703 0.593 102.022 0.780
201706 0.499 102.752 0.651
201709 0.602 103.279 0.782
201712 0.638 103.793 0.824
201803 0.709 103.962 0.915
201806 0.539 104.875 0.689
201809 0.578 105.679 0.734
201812 0.645 105.912 0.817
201903 0.671 105.886 0.850
201906 0.511 106.742 0.642
201909 0.541 107.214 0.677
201912 0.621 107.766 0.773
202003 0.641 106.563 0.807
202006 0.691 107.498 0.862
202009 0.752 107.635 0.937
202012 2.068 108.296 2.561
202103 2.084 108.360 2.579
202106 2.105 108.928 2.592
202109 2.107 110.338 2.561
202112 2.045 112.486 2.438
202203 2.026 114.825 2.366
202206 1.724 118.384 1.953
202209 1.678 122.296 1.840
202212 1.882 126.365 1.997
202303 1.973 127.042 2.083
202306 1.732 129.407 1.795
202309 1.774 130.224 1.827
202312 1.960 131.912 1.993
202403 2.062 132.205 2.092
202406 1.488 132.716 1.504
202409 1.565 132.304 1.586
202412 1.551 132.987 1.564
202503 1.736 132.825 1.753
202506 1.195 133.699 1.199
202509 1.285 133.480 1.291
202512 1.398 133.390 1.406
202603 1.488 133.560 1.494
202606 1.144 134.110 1.144

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is BioGaia AB (BGLAF) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of $12.20 is trading 2.9% below its estimated GF Value™ of $12.57. GuruFocus considers BioGaia AB to be Fairly Valued.

Key valuation signals for BGLAF:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $12.57 vs. price of $12.20 (2.9% below fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the BGLAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioGaia AB Business Description

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
100GF Score

Get the complete analysis for BGLAF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.20
Price
$12.57
GF Value